• FirefoxInstall the new Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.11%

    More On BIOCON.NS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Biocon Limited (BIOCON.NS)

    -NSE
    434.95 Up 7.20(1.68%) Mar 5, 4:59AM EST
    Add to Portfolio
    Prev Close:427.75
    Open:428.95
    Bid:N/A
    Ask:434.95
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:425.70 - 436.50
    52wk Range:402.30 - 553.60
    Volume:334,089
    Avg Vol (3m):611,016
    Market Cap:85.42B
    P/E (ttm):21.27
    EPS (ttm):20.45
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in INR.

    Key Statistics

    Forward P/E (1 yr):18.76
    P/S (ttm):2.82
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Mar-15) :20.08
    Quarterly EPS Est (Mar-15) :N/A
    Mean Recommendation*:3.1
    PEG Ratio (5 yr expected):1.69

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biocon Limited develops and sells biotechnology products for the pharmaceutical sector in India and internationally. It offers active pharmaceutical ingredients, including cardiovascular agents, anti-obesity agents, immunosuppressants, opthalmics,... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback